{
    "xml": "<topic id=\"PHP4650\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/teriparatide\" basename=\"teriparatide\" title=\"TERIPARATIDE\">\n<title>TERIPARATIDE</title>\n<body>\n<data name=\"vtmid\">398823001</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_400337305\" title=\"Parathyroid hormones and analogues\">Parathyroid hormones and analogues</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP64411\" outputclass=\"indicationsAndDose\" rev=\"1.14\" parent=\"/drugs/teriparatide\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures</p>\n<p outputclass=\"therapeuticIndication\">Treatment of corticosteroid-induced osteoporosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>20&#8239;micrograms daily for maximum duration of treatment 24 months (course not to be repeated).</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64486\" outputclass=\"contraindications\" rev=\"1.6\" parent=\"/drugs/teriparatide\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Bone metastases</ph>; <ph outputclass=\"contraindication\">hyperparathyroidism</ph>; <ph outputclass=\"contraindication\">metabolic bone diseases</ph>; <ph outputclass=\"contraindication\">Paget&#8217;s disease</ph>; <ph outputclass=\"contraindication\">pre-existing hypercalcaemia</ph>; <ph outputclass=\"contraindication\">previous radiation therapy to the skeleton</ph>; <ph outputclass=\"contraindication\">skeletal malignancies</ph>; <ph outputclass=\"contraindication\">unexplained raised alkaline phosphatase</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64294\" outputclass=\"sideEffects\" rev=\"1.7\" parent=\"/drugs/teriparatide\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anaemia</ph>; <ph outputclass=\"sideEffect\">arthralgia</ph>; <ph outputclass=\"sideEffect\">asthenia</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">fatigue</ph>; <ph outputclass=\"sideEffect\">gastro-intestinal disorders</ph>; <ph outputclass=\"sideEffect\">haemorrhoids</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">increased sweating</ph>; <ph outputclass=\"sideEffect\">muscle cramps</ph>; <ph outputclass=\"sideEffect\">myalgia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">palpitation</ph>; <ph outputclass=\"sideEffect\">reflux</ph>; <ph outputclass=\"sideEffect\">sciatica</ph>; <ph outputclass=\"sideEffect\">vertigo</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hypercalcaemia</ph>; <ph outputclass=\"sideEffect\">injection-site reactions</ph>; <ph outputclass=\"sideEffect\">urinary disorders</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hypersensitivity reactions</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64378\" outputclass=\"pregnancy\" parent=\"/drugs/teriparatide\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64531\" outputclass=\"breastFeeding\" parent=\"/drugs/teriparatide\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64337\" outputclass=\"renalImpairment\" parent=\"/drugs/teriparatide\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Caution in moderate impairment; avoid if severe.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64193\" outputclass=\"nationalFunding\" rev=\"1.39\" parent=\"/drugs/teriparatide\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA161</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Alendronate, etidronate, risedronate, raloxifene, strontium ranelate, and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008)</p>\r\n<p>This guideline recommends treatment options for the secondary prevention of osteoporotic fractures in postmenopausal women with confirmed osteoporosis who have also sustained a clinically apparent osteoporotic fracture.</p>\r\n<p>\r\n<b>Teriparatide</b> is recommended as an alternative for women:</p>\r\n<ul>\r\n<li>in whom alendronate or risedronate, <i>or</i> strontium ranelate are contra-indicated or not tolerated, <b>or</b> where treatment with alendronate or risedronate has been unsatisfactory (indicated by another fragility fracture and a decline in bone mineral density despite treatment for 1 year) <b>and</b>\r\n</li>\r\n<li>who comply with particular combinations of bone mineral density measurement, age, and number of fractures, as indicated in the full NICE guidance.</li>\r\n</ul>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA161\">www.nice.org.uk/TA161</xref>\n</sectiondiv>\n</sectiondiv>\r\n<sectiondiv outputclass=\"smcDecisions\">\r\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\r\n<sectiondiv outputclass=\"smcDecision\">\r\n<sectiondiv>\r\n<p>The <i>Scottish Medicines Consortium</i> has advised (December 2003) that the use of teriparatide (<i>Forsteo</i>\r\n<tm tmtype=\"reg\"/>) in postmenopausal women should be restricted to the treatment of established (severe) osteoporosis and should be initiated by specialists experienced in the treatment of osteoporosis.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP4650-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/teriparatide\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75027\" title=\"Solution for injection\" namespace=\"/drugs/teriparatide/solution-for-injection\">Solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78314\" namespace=\"/treatment-summaries/bone-metabolism\" title=\"Bone metabolism\" count=\"1\" rel=\"backlink\">Bone metabolism</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75027\" namespace=\"/drugs/teriparatide/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP4650",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/teriparatide",
    "basename": "teriparatide",
    "title": "TERIPARATIDE",
    "vtmid": "398823001",
    "drugClassification": [
        "Parathyroid hormones and analogues"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures",
                        "html": "Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures"
                    },
                    {
                        "textContent": "Treatment of corticosteroid-induced osteoporosis",
                        "html": "Treatment of corticosteroid-induced osteoporosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "20 micrograms daily for maximum duration of treatment 24 months (course not to be repeated).",
                        "html": "<p>20&#8239;micrograms daily for maximum duration of treatment 24 months (course not to be repeated).</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Bone metastases",
                "html": "Bone metastases"
            },
            {
                "type": "contraindications",
                "textContent": "hyperparathyroidism",
                "html": "hyperparathyroidism"
            },
            {
                "type": "contraindications",
                "textContent": "metabolic bone diseases",
                "html": "metabolic bone diseases"
            },
            {
                "type": "contraindications",
                "textContent": "Paget&#8217;s disease",
                "html": "Paget&#8217;s disease"
            },
            {
                "type": "contraindications",
                "textContent": "pre-existing hypercalcaemia",
                "html": "pre-existing hypercalcaemia"
            },
            {
                "type": "contraindications",
                "textContent": "previous radiation therapy to the skeleton",
                "html": "previous radiation therapy to the skeleton"
            },
            {
                "type": "contraindications",
                "textContent": "skeletal malignancies",
                "html": "skeletal malignancies"
            },
            {
                "type": "contraindications",
                "textContent": "unexplained raised alkaline phosphatase",
                "html": "unexplained raised alkaline phosphatase"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Anaemia",
                        "html": "Anaemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "arthralgia",
                        "html": "arthralgia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "asthenia",
                        "html": "asthenia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspnoea",
                        "html": "dyspnoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "fatigue",
                        "html": "fatigue",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "gastro-intestinal disorders",
                        "html": "gastro-intestinal disorders",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "haemorrhoids",
                        "html": "haemorrhoids",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "increased sweating",
                        "html": "increased sweating",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "muscle cramps",
                        "html": "muscle cramps",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "myalgia",
                        "html": "myalgia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "palpitation",
                        "html": "palpitation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "reflux",
                        "html": "reflux",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "sciatica",
                        "html": "sciatica",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vertigo",
                        "html": "vertigo",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Hypercalcaemia",
                        "html": "Hypercalcaemia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "injection-site reactions",
                        "html": "injection-site reactions",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "urinary disorders",
                        "html": "urinary disorders",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Hypersensitivity reactions",
                        "html": "Hypersensitivity reactions",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid.",
                "html": "<p>Avoid.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid.",
                "html": "<p>Avoid.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Caution in moderate impairment; avoid if severe.",
                "html": "<p>Caution in moderate impairment; avoid if severe.</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA161",
                        "label": "www.nice.org.uk/TA161"
                    }
                ],
                "fundingIdentifier": "NICE TA161",
                "textContent": "Alendronate, etidronate, risedronate, raloxifene, strontium ranelate, and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008) This guideline recommends treatment options for the secondary prevention of osteoporotic fractures in postmenopausal women with confirmed osteoporosis who have also sustained a clinically apparent osteoporotic fracture. Teriparatide is recommended as an alternative for women: in whom alendronate or risedronate, or strontium ranelate are contra-indicated or not tolerated, or where treatment with alendronate or risedronate has been unsatisfactory (indicated by another fragility fracture and a decline in bone mineral density despite treatment for 1 year) and who comply with particular combinations of bone mineral density measurement, age, and number of fractures, as indicated in the full NICE guidance.\n\nwww.nice.org.uk/TA161",
                "html": "<p outputclass=\"title\">Alendronate, etidronate, risedronate, raloxifene, strontium ranelate, and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008)</p> <p>This guideline recommends treatment options for the secondary prevention of osteoporotic fractures in postmenopausal women with confirmed osteoporosis who have also sustained a clinically apparent osteoporotic fracture.</p> <p> <b>Teriparatide</b> is recommended as an alternative for women:</p> <ul> <li>in whom alendronate or risedronate, <i>or</i> strontium ranelate are contra-indicated or not tolerated, <b>or</b> where treatment with alendronate or risedronate has been unsatisfactory (indicated by another fragility fracture and a decline in bone mineral density despite treatment for 1 year) <b>and</b> </li> <li>who comply with particular combinations of bone mineral density measurement, age, and number of fractures, as indicated in the full NICE guidance.</li> </ul><xref format=\"html\" href=\"http://www.nice.org.uk/TA161\">www.nice.org.uk/TA161</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75027",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78314",
                "label": "Bone metabolism",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75027",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}